Skip to content
Independent analysis of NHS open data
PharmaInsight

Lipozate 400mg modified-release tablets

0212000D0BGAAAB · Cardiovascular System
Data updated May 2026
27items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£236

Net ingredient cost · May 2026

NHSBSA PCA

182items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Lipozate 400mg modified-release tablets: national items dispensed by month

0 15.5 31 Jun 2023 Dec 2023 May 2024 Oct 2024 Mar 2025 Aug 2025 May 2026 27 Jun 2023: 1 Jul 2023: 1 Sep 2023: 4 Oct 2023: 4 Nov 2023: 4 Dec 2023: 1 Jan 2024: 5 Feb 2024: 5 Mar 2024: 4 Apr 2024: 11 May 2024: 8 Jun 2024: 7 Jul 2024: 9 Aug 2024: 18 Sep 2024: 5 Oct 2024: 14 Nov 2024: 7 Dec 2024: 5 Jan 2025: 4 Feb 2025: 4 Mar 2025: 4 Apr 2025: 7 May 2025: 2 Jun 2025: 2 Jul 2025: 10 Aug 2025: 8 Sep 2025: 9 Oct 2025: 9 Nov 2025: 13 Dec 2025: 7 Jan 2026: 22 Feb 2026: 31 Mar 2026: 24 Apr 2026: 20 May 2026: 27

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Bezafibrate. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).